Shingles (Herpes Zoster): A Physician's Complete Guide

What Is Shingles?

Shingles — known medically as herpes zoster — is a viral infection caused by the reactivation of varicella-zoster virus (VZV). If you had chickenpox, the virus never left your body. After the initial infection, VZV retreats into the sensory nerve ganglia — clusters of nerve cells along your spinal cord and cranial nerves — and lies dormant, sometimes for decades.

When the immune system loses its grip on the virus, VZV travels back down the nerve fiber to the skin. The result is the classic shingles rash: a painful, blistering eruption that follows the path of a single dermatome — the strip of skin supplied by one sensory nerve root. This unilateral, band-like distribution on one side of the body is what separates shingles from almost every other rash I see in clinical practice.

In the United States, approximately 1 million cases occur each year.^[1] Lifetime risk sits at about 1 in 3, rising to nearly 1 in 2 for those who reach age 85. Risk rises sharply after age 50, driven primarily by the natural decline in VZV-specific cell-mediated immunity that comes with aging.

Symptoms

The Prodromal Phase

Before the rash appears, most patients go through a prodromal period lasting 1–5 days. During this window, you may notice burning, tingling, itching, or shooting pain along one side of the chest, abdomen, face, or extremity. The skin may feel hypersensitive to the touch — even light contact from clothing can be uncomfortable. Mild fever, headache, and fatigue sometimes accompany this phase.

This prodrome is clinically important because it is when antiviral treatment is most effective. Many patients come to me thinking they pulled a muscle or have a pinched nerve — and in some cases, the diagnosis is genuinely uncertain until the rash appears. If you have unexplained unilateral nerve pain and are over 50, call your doctor that day.

Rash Progression

The rash typically appears 2–5 days after prodromal symptoms start. It begins as a red, blotchy area that quickly develops into grouped vesicles — small fluid-filled blisters sitting on a red base. New blisters continue forming for 3–5 days. Over the following 7–10 days, they cloud over, rupture, and crust. Complete skin healing usually takes 2–4 weeks.

The distribution is the diagnostic hallmark: the rash stays strictly on one side of the body, typically wrapping around the torso in a belt-like pattern (hence the old name "shingles," from the Latin cingulum, meaning belt). The thoracic dermatomes (T3–L2) are affected in about half of all cases. The trigeminal nerve — particularly the ophthalmic branch — is the second most common site, and involvement here requires urgent evaluation.

Pain Characteristics

Pain is the defining symptom of shingles for most patients. It can range from a dull ache to sharp, stabbing, electric sensations. Allodynia — pain from stimuli that would not normally cause pain, like a gentle breeze or a shirt — is common and can be profoundly distressing. The pain often continues even after the skin heals completely.

Causes and Risk Factors

You cannot develop shingles without a prior VZV infection. Anyone who had chickenpox carries the dormant virus. Risk of reactivation is directly tied to how well your immune system is suppressing the latent virus.

Primary Risk Factors

• Age over 50: The single strongest risk factor. VZV-specific T-cell immunity wanes with age, and risk rises sharply after 50. Incidence and complication rates both increase steadily through the eighth and ninth decades of life.^[1]
• Immunosuppression: Any condition or treatment that weakens the immune system dramatically raises shingles risk. This includes HIV, active cancer (particularly leukemia and lymphoma), bone marrow or solid organ transplants, and long-term use of corticosteroids or immunosuppressive drugs. Hospitalized patients with compromised immunity account for roughly 30% of severe shingles cases.^[1]
• Psychological and physical stress: Prolonged stress suppresses cell-mediated immunity. Many patients recall a major stressor — illness, surgery, bereavement, or extreme fatigue — in the weeks before their shingles episode. The relationship is biologically plausible, though hard to quantify.
• Serious illness or surgery: Major trauma, critical illness, or major surgery can temporarily depress immune function enough to allow VZV reactivation.
• Sex: Shingles is modestly more common in women than men, though the mechanism is not fully understood.^[8]

The 72-Hour Treatment Window

This is the most clinically important concept in this entire guide. Antiviral therapy for shingles is time-sensitive in a way that few other outpatient conditions are. The 72-hour window is real, it matters, and missing it has lasting consequences.

Here is why timing matters so much: VZV is actively replicating during the early phase of the outbreak. Antivirals stop viral replication. Once the virus finishes its assault on the nerve fiber — damaging sensory neurons, triggering inflammation, and disrupting nerve signal processing — the damage is largely done. Antivirals cannot repair injured nerves, but they can prevent further injury if given early enough.

Starting antivirals within 72 hours of rash onset:^[1]

• Accelerates healing of the skin lesions
• Reduces the formation of new blisters
• Decreases the severity of acute pain
• Reduces the duration of viral shedding
• Lowers the risk of developing postherpetic neuralgia

Treatment is still worth initiating after 72 hours in patients who are immunocompromised, have moderate or severe pain, have ophthalmic or ear involvement, or are still developing new lesions — but the benefit is progressively smaller the longer you wait.

Treatment

Antiviral Medications

Three oral antivirals are available for shingles. All three inhibit viral DNA replication. Valacyclovir is my preferred choice for most patients because of its favorable dosing schedule and superior oral bioavailability compared to acyclovir.

For immunocompromised patients with severe disease, disseminated rash, or neurologic involvement, intravenous acyclovir (10–15 mg/kg every 8 hours) is the standard of care and requires hospitalization.^[5] Dose adjustments are needed for patients with reduced kidney function — always check the creatinine before prescribing, particularly in older adults.

Pain Management During Acute Shingles

Controlling pain during the acute phase matters both for quality of life and potentially for reducing nerve sensitization that contributes to PHN. My approach is stepwise:

• Mild pain: Acetaminophen (up to 3,000 mg/day in otherwise healthy adults) or NSAIDs (ibuprofen, naproxen) with food and adequate hydration
• Moderate pain: Add gabapentin 300 mg at bedtime, titrated up as tolerated, or a tricyclic antidepressant such as nortriptyline 10–25 mg at night
• Severe pain: Short-term opioid analgesics may be necessary while antivirals take effect — typically 3–5 days. I use the lowest effective dose for the shortest time needed.
• Topical options: Lidocaine gel or cool compresses on the affected skin can provide short-term relief without systemic effects.

Corticosteroids (such as prednisone) are sometimes added to the antiviral regimen. They reduce acute inflammation and may improve quality of life in the short term, but evidence that they significantly reduce PHN risk is limited. I use them selectively — mainly in older patients with severe acute pain — and only when there are no contraindications.

Postherpetic Neuralgia (PHN)

PHN is the most common and most debilitating complication of shingles. It is defined as pain persisting at or beyond 90 days from the onset of the shingles rash. The pain arises because VZV physically damages sensory nerve fibers during the acute outbreak, leaving them misfiring and sending pain signals even with no ongoing viral activity.

PHN affects roughly 10–20% of shingles patients over age 50.^[7] Risk rises steeply with age — in one large UK primary-care study, PHN occurred in 8% of patients aged 50–54 but 21% of those aged 80–84.^[7] Other significant risk factors include severe acute pain, prominent prodromal symptoms before the rash, extensive rash area, and female sex.^[6]

Prevention

The most effective strategies for PHN prevention are starting antivirals promptly during the acute episode, and getting vaccinated with Shingrix before ever developing shingles. Shingrix reduced PHN incidence by 91.2% in adults aged 50 and older in clinical trials — a dramatic result.^[3]

Treatment of Established PHN

Once PHN is established, the goal shifts to controlling pain and preserving function. Multiple agents are used:

PHN is not always quickly resolved. Some patients need combination therapy. I often start with low-dose gabapentin at night — it helps both pain and sleep — and add a lidocaine patch for daytime use. Opioids are generally a last resort given their side effect profile in older patients.

The Shingles Vaccine: Shingrix

If there is one thing I want every patient over 50 to take away from this guide, it is this: get the Shingrix vaccine. The efficacy data are among the strongest I have seen for any adult vaccine.

Efficacy Data

Shingrix (recombinant zoster vaccine, adjuvanted) was evaluated in the landmark ZOE-50 and ZOE-70 trials. In ZOE-50, which enrolled adults aged 50 and older, the overall vaccine efficacy against herpes zoster was 97.2% (95% CI, 93.7–99.0).^[3] In ZOE-70, which enrolled adults aged 70 and older, efficacy was 89.8% (95% CI, 84.2–93.7).^[3]

In the pooled analysis across both trials, overall vaccine efficacy was 91.3%.^[3] For PHN specifically, Shingrix showed 91.2% efficacy in adults aged 50 and older and 88.8% in those aged 70 and older.^[3] These numbers stand in stark contrast to the discontinued Zostavax, which had only 41% efficacy in adults aged 70–79 and just 18% in those 80 and older.^[2]

Who Should Get It and When

The CDC recommends Shingrix for:^[2]

• All immunocompetent adults aged 50 and older, regardless of prior shingles history or prior Zostavax vaccination
• Adults aged 19 and older who are immunodeficient or immunosuppressed (including those receiving immunosuppressive therapy, with HIV, or with hematologic malignancies)

The series is two doses given 2–6 months apart for most adults. For immunocompromised individuals who need faster protection, the second dose can be given 1–2 months after the first. No serologic screening for prior varicella is needed before vaccination — the CDC advises against it because false negatives are common and the test adds a barrier without changing the recommendation.^[2]

Timing After a Shingles Episode

There is no mandatory waiting period after recovering from shingles before getting vaccinated. The only rule is that you should not receive Shingrix while in the middle of an active outbreak. Once the acute episode resolves, you can be vaccinated at any time. I typically recommend waiting 2–4 weeks as a practical matter to let the immune response to the acute infection settle, though this is not a formal CDC requirement.

Side Effects

Shingrix causes more injection-site reactions and systemic symptoms (arm soreness, fatigue, muscle aches, fever) than many other adult vaccines. These reactions reflect the adjuvant system working as designed to generate a strong immune response. They typically resolve within 2–3 days and are not a reason to avoid the vaccine or skip the second dose. I tell patients to expect it, plan for a day of feeling off, and know that it means the vaccine is doing its job.

Complications

Herpes Zoster Ophthalmicus (HZO)

When shingles affects the ophthalmic branch of the trigeminal nerve (V1), it can involve the eye itself. Herpes zoster ophthalmicus accounts for roughly 10–25% of all shingles cases and is one of the more serious presentations I manage.

The Hutchinson sign — a vesicle on the tip or side of the nose — is a clinical warning that the nasociliary branch of the trigeminal nerve is involved and that ocular disease is likely. Eye findings can include conjunctivitis, keratitis (corneal inflammation), uveitis, and, in severe cases, acute retinal necrosis or elevated intraocular pressure leading to glaucoma.

Any patient with a shingles rash involving the forehead or around the eye needs same-day ophthalmology referral. Oral antivirals — valacyclovir 1,000 mg three times daily for at least 7 days — should be started immediately without waiting for the ophthalmology appointment.^[5] Antiviral treatment reduces the risk of chronic ocular complications by 20–30%.^[4b] Topical anesthetics should never be used on the eye in this setting — they are corneal toxic.

Ramsay Hunt Syndrome (Herpes Zoster Oticus)

Ramsay Hunt syndrome occurs when VZV reactivates in the geniculate ganglion of the facial nerve (cranial nerve VII). The classic triad is:

• Painful vesicles in the ear canal, on the earlobe, or on the soft palate
• Facial nerve palsy (weakness or paralysis of one side of the face)
• Sensorineural hearing loss, tinnitus, and vertigo

Ramsay Hunt syndrome is more severe than typical facial nerve palsy from other causes. Without prompt treatment, permanent facial weakness and hearing loss are real risks. Treatment is oral antivirals plus corticosteroids (prednisone), initiated as quickly as possible.^[10]

Disseminated Zoster

In immunocompromised patients, VZV can spread beyond a single dermatome, producing a widespread rash with more than 20 lesions outside the primary and adjacent dermatomes. Visceral dissemination — affecting lungs, liver, or central nervous system — is a life-threatening complication requiring IV acyclovir and hospital admission.

Other Neurologic Complications

Less common but serious neurologic complications include encephalitis, myelitis, stroke (VZV vasculopathy affecting cerebral arteries), and cranial nerve palsies affecting vision, hearing, and swallowing. Patients who develop new neurologic symptoms during or after a shingles episode need urgent evaluation.

When to See a Doctor

Use this decision framework to guide your response:

Red Flags

In family medicine, shingles has a list of scenarios that demand immediate action. I want to spell these out clearly because delays in any of these situations can lead to permanent consequences.

• Eye involvement: Any rash near the eye, vision changes, eye pain, or redness in a patient with active shingles is a same-day emergency. VZV can destroy corneal sensation permanently, leading to neurotrophic keratopathy, chronic eye disease, and vision loss.
• Facial nerve involvement: Rash in the ear canal, facial weakness, drooling, or the inability to close one eye are signs of Ramsay Hunt syndrome. Start antivirals and steroids immediately. Outcomes are significantly better the earlier treatment begins.
• Immunocompromised patients: These patients can develop rapidly disseminating disease. A shingles rash in someone on chemotherapy, after organ transplant, or with advanced HIV needs urgent assessment — often same day — and a low threshold for hospitalization.
• Disseminated rash: More than 20 vesicles outside the primary dermatome indicates possible viral dissemination. This requires immediate IV antiviral therapy in a hospital setting.
• Neurologic symptoms: New confusion, severe headache, focal weakness, or changes in vision or hearing during a shingles episode require emergency evaluation for encephalitis or VZV vasculopathy.

Frequently Asked Questions